EUDA Health Holdings Limited (NASDAQ:EUDA) Short Interest Down 16.3% in December

EUDA Health Holdings Limited (NASDAQ:EUDA) was the recipient of a large decrease in short interest during the month of December. As of December 15th, there was short interest totaling 36,489 shares, a decrease of 16.3% from the November 30th total of 43,604 shares. Based on an average trading volume of 62,385 shares, the days-to-cover ratio is presently 0.6 days. Currently, 0.1% of the company’s stock are sold short. Currently, 0.1% of the company’s stock are sold short. Based on an average trading volume of 62,385 shares, the days-to-cover ratio is presently 0.6 days.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of EUDA Health in a research report on Tuesday, October 14th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

Hedge Funds Weigh In On EUDA Health

A hedge fund recently raised its stake in EUDA Health stock. Citadel Advisors LLC boosted its position in EUDA Health Holdings Limited (NASDAQ:EUDA) by 57.7% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 44,631 shares of the company’s stock after purchasing an additional 16,321 shares during the period. Citadel Advisors LLC owned approximately 0.12% of EUDA Health worth $78,000 as of its most recent SEC filing. Institutional investors and hedge funds own 4.35% of the company’s stock.

EUDA Health Stock Performance

EUDA Health stock opened at $2.34 on Wednesday. EUDA Health has a 1 year low of $1.03 and a 1 year high of $4.70. The firm’s 50-day moving average is $2.62 and its 200-day moving average is $2.64. The company has a market cap of $88.48 million, a P/E ratio of -19.50 and a beta of -0.15.

EUDA Health Company Profile

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.